INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,000 | -75.0% | 6,154 | +1.5% | 0.00% | – |
| Q1 2016 | $32,000 | -8.6% | 6,061 | +34.2% | 0.00% | – |
| Q4 2015 | $35,000 | -31.4% | 4,515 | -25.0% | 0.00% | – |
| Q3 2015 | $51,000 | +168.4% | 6,022 | +252.4% | 0.00% | – |
| Q2 2015 | $19,000 | 0.0% | 1,709 | +28.5% | 0.00% | – |
| Q1 2015 | $19,000 | -13.6% | 1,330 | +0.2% | 0.00% | – |
| Q4 2014 | $22,000 | 0.0% | 1,327 | -17.6% | 0.00% | – |
| Q3 2014 | $22,000 | +15.8% | 1,610 | +5.3% | 0.00% | – |
| Q2 2014 | $19,000 | +18.8% | 1,529 | +10.7% | 0.00% | – |
| Q1 2014 | $16,000 | -15.8% | 1,381 | +2.8% | 0.00% | – |
| Q4 2013 | $19,000 | -76.8% | 1,343 | -71.3% | 0.00% | -100.0% |
| Q3 2013 | $82,000 | +105.0% | 4,680 | +91.6% | 0.00% | – |
| Q2 2013 | $40,000 | – | 2,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |